The acetylation of ACSL4 could inhibit FBXO10-mediated K48-linked ubiquitination, resulting in enhanced protein stability of ACSL4, thereby promoting the double-edged sword effect: malignant progression and ferroptosis of NPC cells (Fig. 10). The gene discussed is ACSL4; the disease is nasopharyngeal carcinoma.